The expression of CD63 dramatically decreased in cancer cells (HepG2, MDA-MB-231 and PC3) after receiving 1 h of cannabidiol treatment, suggesting that the underlying mechanism involves its interference with CD63 [217]. The gene discussed is CD63; the disease is cancer.